Pulmonary Disease · Vero Beach, FL
NPI
1710987292
Since 2005
Specialty
Pulmonary Disease
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3735 11th Cir, Suite 103
Vero Beach, FL, 32960
Phone (772) 770-4888
Groups this clinician bills Medicare through
Medicare paid, 2024
$703K
8,889 services
Medicare patients, 2024
2,577
Average age 76
Drug cost, 2024
$2.3M
5,168 prescriptions
Company payments, 2025
$11K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John S Suen was code 99213 (office e&m - established), 2,757 times for 1,541 patients. In total John S Suen billed 8,889 services in 51 codes, and Medicare paid $703K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,757 | 1,541 | $66.71 | $184K |
| 99214 Office E&M - Established | Office | 1,320 | 1,033 | $93.99 | $124K |
| 94010 Pulmonary Function Testing | Office | 817 | 791 | $20.76 | $17K |
| 94729 Pulmonary Function Testing | Office | 690 | 686 | $42.04 | $29K |
| 94726 Pulmonary Function Testing | Office | 690 | 685 | $41.22 | $28K |
| 99203 Office E&M - New | Office | 533 | 533 | $80.85 | $43K |
| 95012 Pulmonary | Office | 338 | 333 | $14.74 | $4,981 |
| 99232 Hospital E&M - Subsequent | Facility | 299 | 123 | $61.04 | $18K |
| 95810 Sleep Study | Office | 195 | 184 | $487.62 | $95K |
| 99223 Hospital E&M - Initial | Facility | 168 | 150 | $131.73 | $22K |
| 95811 Sleep Study | Office | 140 | 132 | $506.62 | $71K |
| 94618 Pulmonary Function Testing | Office | 125 | 108 | $26.27 | $3,283 |
| 76604 Ultrasound - Nonspecific | Office | 88 | 44 | $43.18 | $3,800 |
| 31628 Bronchoscopy | Facility | 63 | 60 | $35.09 | $2,211 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 60 | 59 | $66.22 | $3,973 |
By year: 2022 $863K for 9,779 services; 2023 $806K for 9,467 services; 2024 $703K for 8,889 services.
Medicare prescription drug claims, 2024
In 2024, the drug John S Suen prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 826 prescriptions and refills. In total John S Suen wrote 5,168 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 826 | 988 | 274 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 609 | 856 | 116 | $525K |
| Breo Ellipta Fluticasone/Vilanterol | 265 | 380 | 50 | $146K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 176 | 251 | 45 | $110K |
| Montelukast Sodium Generic | 173 | 455 | 56 | $2,009 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 142 | 214 | 44 | $19K |
| Ventolin Hfa Albuterol Sulfate | 140 | 156 | 42 | $9,796 |
| Spiriva Respimat Tiotropium Bromide | 136 | 173 | 34 | $88K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 134 | 202 | 36 | $94K |
| Prednisone Generic | 133 | 167 | 72 | $1,233 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 131 | 173 | 35 | $106K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 125 | 198 | 47 | $19K |
| Clonazepam Generic | 118 | 135 | 20 | $681 |
| Eszopiclone Generic | 98 | 104 | 23 | $1,660 |
| Roflumilast Generic | 94 | 142 | 19 | $6,589 |
Brand drugs: 2,681 claims; generic drugs: 2,487 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John S Suen $11K ($11K in general payments such as food, travel and fees) from 30 companies. The largest payer was Intuitive Surgical, Inc. with $5,141.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 14 | $5,141 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $777 |
| Actelion Pharmaceuticals US, Inc. JNJ | 11 | $708 |
| Insmed, Inc. INSM | 26 | $541 |
| GlaxoSmithKline, LLC. GSK | 24 | $444 |
| Harmony Biosciences LLC HRMY | 9 | $403 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $332 |
| Inspire Medical Systems, Inc. INSP | 4 | $313 |
| Grifols USA, LLC | 6 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $250 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.